Pasithea Therapeutics
KTTA · NASDAQ
$0.41−$0.0023 (−0.56%)TodayMarket closed ·
Prev close $0.4123
Who owns KTTA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 58.5% of KTTA’s shares.
- Coastlands Capital LP11.5%
- Cable Car Capital, LP9.0%
- Stonepine Capital Management, LLC6.6%
- Adage Capital Management, L.P.6.3%
- Next 6 largest institutions25.2%
- All other shareholders41.5%
| Holder | Shares | % of shares |
|---|---|---|
| Coastlands Capital LP | 3.84M | 11.48% |
| Cable Car Capital, LP | 3.00M | 8.98% |
| Stonepine Capital Management, LLC | 2.20M | 6.59% |
| Adage Capital Management, L.P. | 2.10M | 6.29% |
| Janus Henderson Investors | 2.10M | 6.29% |
| Opaleye Management Inc. | 2.05M | 6.14% |
| Columbia Threadneedle Investments (US) | 1.86M | 5.58% |
| Squadron Capital Management LLC | 1.00M | 2.99% |
| AdvisorShares Investments, LLC | 937.55K | 2.81% |
| Vivo Capital, LLC | 465.47K | 1.39% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| AdvisorShares Psychedelics ETF | 1.12M | 3.36% |
| Vanguard Extended Market Index Fund | 126.28K | 0.38% |
| Fidelity Extended Market Index Fund | 57.82K | 0.17% |
| Fidelity NASDAQ Composite Index Fund | 13.44K | 0.04% |
| Fidelity Series Total Market Index Fund | 7.97K | 0.02% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $53.00K (1 trade) of KTTA on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Coastlands Capital LP | Buy | 100.00K | $53.00K |
| Marques Tiago | Award | 1.76M | — |
| Dumesnil Simon | Award | 152.78K | — |
| Krishnan Kartik | Award | 1.13M | — |
| Leahy Emer | Award | 152.78K | — |
| Schneiderman Daniel H | Award | 1.13M | — |
| Novak Alfred J | Award | 152.78K | — |
| STEINMAN LAWRENCE | Award | 152.78K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 159.83K
- Days to cover
- 1.06
- % of shares outstanding
- 0.48%
- Average daily volume
- 151.14K
- Change since last report
- −40.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.